FDA approves Merck pneumococcal disease vaccine designed for adults

Zoom In IconArrows pointing outwardsMerck's new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck's new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker said.Merck's shot, called Capvaxive, specifically protects...

Read more...

ADSK, AVGO, AMCX and more

Check out the companies making headlines in midday trading: Virgin Galactic — The struggling space company slid 15% as the stock's 1-for-20 reverse stock split took effect. The company was trying to get its stock back above $1 a share after a steady slide over the past three years....

Read more...